Post by
MrMugsy on Jun 22, 2021 10:46pm
Conference Call Tomorrow ...
Raymond James tomorrow at 8:40 AM.
Based on the Bear Creek call today - sounds like a few things might be made a little clearer tomorrow (from what others are saying).
Someone remind Yukon not to take my advice ... he's too good to take that call anyway.
: )
Comment by
themagicbox on Jun 23, 2021 9:18am
were you able to catch it any details? It just ended.
Comment by
GameChangerBet on Jun 23, 2021 9:21am
No new material from what I heard. Although reassuring of all the material positives in the near-intermmediate term.
Comment by
MrMugsy on Jun 23, 2021 9:48am
Finished off the discussion with a reminder that OTENA peak sales of $4B is in reference to OA in 4 markets. Looking at all indications ... OTENA is probably looking at $10B for peak. If I understood that final comment. Only had time for two questions
Comment by
GameChangerBet on Jun 23, 2021 11:20am
All I know is that Otena has a very high probability of getting FDA approval and once that happens these guys will be generating million of dollars of free cash flow which will keep growing, month over month and year over year until peak sales.
Comment by
JimmyJ on Jun 23, 2021 1:12pm
That's one option. Other alternatives could be: 1) License Otena to BP; 2) Sell Otena to BP; 3) Sell the company with all pipeline products, R&D, IP and resources to BP. I'm hoping for a quick exit (option 3).
Comment by
GameChangerBet on Jun 23, 2021 1:15pm
Yes absolutely. What I meant by generating cash flow is once the product hits the market, likely via a licensing deal. That's what they're targeting. But yea without a doubt option 3 would be a great news release to wake up to
Comment by
IrishCanuck on Jun 23, 2021 2:24pm
Something along the lines of "Dosing once daily with 150mg would cost payors $6.00 per day and with 98% profit margin, which is in line with typical pharmaceutical companies, it's shaping to be nice" got me FIIRREEEEDDDDD UPPPPPPP. Like YEA DAN THAT WOULD BE VERY NICE LOL
Comment by
MrMugsy on Jun 23, 2021 2:50pm
Irish ... agreed that the $6/day and high profit margin plays nicely during present partnering discussions. I also think the 150 mg was a separate thought from Joe Stauffer indicating a confidence in that dose, with a chance for lower. Just the way I remember it - I might be wrong.
Comment by
MrMugsy on Jun 24, 2021 10:20am
And that's why we needed cash in the bank ... to buy time ... to have the ability to go into Phase 3 without Big Pharma giving us the gears to accept a less-than-optimal deal. I'd like to think we're driving this bus. Slowly but surely, we'll get to our destination. IMO.